Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Nogo B Receptor (NUS1) (Middle Region) Peptid

NUS1 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN5673737
  • Target Alle Nogo B Receptor (NUS1) Produkte
    Nogo B Receptor (NUS1)
    Protein Region
    Middle Region
    Spezies
    Human
    Quelle
    • 2
    Synthetic
    Applikation
    Blocking Peptide (BP), Western Blotting (WB)
    Sequenz
    YDHQGIFKRN NSRLMDEILK QQQELLGLDC SKYSPEFANS NDKDDQVLNC
    Produktmerkmale
    This is a synthetic peptide designed for use in combination with anti- NUS1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    Nogo B Receptor (NUS1)
    Synonyme
    C6orf68 Peptide, MGC:7199 Peptide, NgBR Peptide, TANGO14 Peptide, 1600027K07Rik Peptide, AU019165 Peptide, AW538011 Peptide, BC003223 Peptide, D10Ertd438e Peptide, NUS1 dehydrodolichyl diphosphate synthase subunit Peptide, NUS1 Peptide, Nus1 Peptide
    Hintergrund
    This gene encodes a type I single transmembrane domain receptor, which is a subunit of cis-prenyltransferase, and serves as a specific receptor for the neural and cardiovascular regulator Nogo-B. The encoded protein is essential for dolichol synthesis and protein glycosylation. This gene is highly expressed in non-small cell lung carcinomas as well as estrogen receptor-alpha positive breast cancer cells where it promotes epithelial mesenchymal transition. This gene is associated with the poor prognosis of human hepatocellular carcinoma patients. Naturally occurring mutations in this gene cause a congenital disorder of glycosylation and are associated with epilepsy. A knockout of the orthologous gene in mice causes embryonic lethality before day 6.5. Pseudogenes of this gene have been defined on chromosomes 13 and X.

    Alias Symbols: NgBR, C6orf68, TANGO14, MGC:7199

    Protein Size: 293
    Gen-ID
    116150
    NCBI Accession
    NM_138459, NP_612468
    UniProt
    Q96E22
Sie sind hier:
Kundenservice